Syntax Bio
Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine
$14.4MSeries A+
Role not disclosedLoading investors…
Activity from announced rounds
Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine
Pioneers ASIC over Dielectric interconnect for high-bandwidth, energy-efficient AI infrastructure connectivity